Tooru to Acquire Plant-Based Milk Machine Startup Mylky for $16.2M
Participants
Why It Matters
The acquisition adds a profitable, high‑growth consumer‑tech asset to Tooru’s portfolio, accelerating its push into the fast‑expanding plant‑based beverage market. It also signals continued consolidation in alternative protein, giving Tooru scale to meet rising demand for sustainable milk alternatives.
Key Takeaways
- •Tooru buys Mylky for $16.2M, financing via cash, debt, shares.
- •Mylky generated $8.8M revenue and $2.9M EBITDA in 2025.
- •Over 70,000 European customers provide strong brand loyalty base.
- •Acquisition lets Tooru expand plant‑based milk machines into UK and co‑brand.
- •Home‑made plant milk costs $0.40 per litre, cutting packaging waste.
Pulse Analysis
The deal between Tooru and Mylky reflects a broader shift toward home‑based, sustainable food production. Consumers increasingly seek control over ingredients, cost savings, and reduced environmental impact, driving demand for appliances that can turn raw nuts and grains into fresh milk in minutes. Mylky’s technology, which produces a litre of oat milk for roughly $0.40, undercuts supermarket prices and eliminates single‑use packaging, aligning with the growing anti‑ultra‑processed food sentiment across Europe and North America.
Financially, Mylky’s performance validates the business model: $8.8 million in revenue and $2.9 million EBITDA for 2025, with Q1 2026 already surpassing forecasts and a projected $10.6 million revenue run‑rate for the year. The acquisition’s structure—combining cash, a $4 million loan note, and $4 million of Tooru equity—demonstrates confidence in the company’s cash‑generating capacity and offers Tooru a levered entry into a niche yet scalable market. By integrating Mylky with its existing gluten‑free and vegan snack brands, Tooru can cross‑sell subscription‑based ingredient kits, creating recurring revenue streams beyond the one‑off machine sale.
Strategically, Tooru aims to roll out Mylky’s machines across the UK and other untapped regions, leveraging the brand’s 70,000‑plus European users as a springboard for rapid market penetration. Co‑branding opportunities with Pulsin, Juvela and OAF could produce bundled wellness packages, enhancing customer lifetime value. This acquisition not only diversifies Tooru’s portfolio but also positions it as a consolidator in the alternative protein sector, where over 70 deals have occurred in the past 18 months, underscoring the industry’s appetite for integrated, consumer‑focused solutions.
Deal Summary
UK wellness‑focused investor Tooru has agreed to acquire Belgian plant‑based milk machine startup Mylky for £12 million ($16.2 million). The transaction, funded with cash, a £3 million loan note and newly issued Tooru shares, gives Tooru 100% ownership and expands its portfolio of health‑focused brands. The acquisition underscores consolidation in the alternative‑protein sector.
Comments
Want to join the conversation?
Loading comments...